Feature | May 30, 2014

Study Finds Bariatric Surgery Prevents Obese Patients From Developing Atrial Fibrillation

First-of-its-kind results presented at Heart Rhythm 2014 shows positive correlation between weight loss surgery and reduced risk of atrial fibrillation

May 30, 2014 — New research has found that bariatric surgery is an effective way to control weight in morbidly obese patients who are at risk for developing atrial fibrillation (AF). Bariatric or weight loss surgery is an operation on the stomach that limits food intake and is typically recommended for patients who are unable to lose weight on their own through diet and exercise.

The first study of its kind to look at the relationship between AF and bariatric surgery on a large patient population was presented at Heart Rhythm 2014, the Heart Rhythm Society’s (HRS) 35th annual scientific sessions.

According to the Centers for Disease Control and Prevention, more than two-thirds of the adult population in the United States is considered to be overweight or obese. Obesity is a known risk factor for arrhythmias like AF, and other risk factors for AF include smoking, high blood pressure and high cholesterol. AF is the most common arrhythmia and affects more than 2.7 million American adults. It is characterized by a rapid and irregular heartbeat when the top chambers of the heart (the atria) quiver (fibrillate) erratically, sometimes faster than 300 times per minute.

“Obesity has become an epidemic in our culture and prevention efforts are more important now than ever,” said Yong-Mei Cha, M.D., FHRS, professor of medicine at Mayo Clinic. “Bariatric surgery is a preventative measure that obese patients may choose to take, and our study shows that the surgery helps them not only lose weight, but also reduces their risk of developing a serious cardiac condition like AF. It is important to continue the conversation about how to help prevent this epidemic from becoming even more widespread.”

The retrospective study was conducted in 438 patients with a body mass index (BMI) of 40 or higher and identified as good candidates for bariatric surgery. Of these patients, 326 elected to undergo surgery for weight reduction and 112 were controls who were managed medically. The diagnosis of AF was documented by electrocardiogram (ECG) or ambulatory monitors and metabolic profiles were collected at baseline and follow-up.

The baseline BMI was different in the patients that underwent surgery versus those who did not have surgery (46.9 vs. 43.2kg/m2). The prevalence of AF at baseline was not significantly different between the two groups (surgical 3.7 percent vs. control 4.5 percent p=0.63) at baseline. After a mean follow-up duration of 7.2±3.7 years, new onset of AF occurred in 3.1 percent of the surgical group, significantly lower than 12.5 percent (p<0.01) in the medically treated group. Additionally, the surgical group had a significant reduction in BMI and improvement in metabolic profile compared to the control group.

For more information: www.hrsonline.org

Related Content

Biotronik, FDA, MR Conditional CRT devices, Iperia HF-T, defibrillator, ProMRI
Technology | Cardiac Resynchronization Therapy Devices (CRT)| May 03, 2016
Biotronik announced U.S. Food and Drug Administration (FDA) approval of Iperia ProMRI HF-T, a cardiac resynchronization...
radiation dose in the cath lab
News | Radiation Dose Management| May 02, 2016
May 2, 2016 — Starting at the Society for Cardiovascular Angiography and Interventions (SCAI) 2016 annual meeting May
AtriCure, AtriClip PRO2 LAA Exclusion System, left atrial appendage, FDA clearance
Technology | Left Atrial Appendage (LAA) Occluders| April 29, 2016
April 29, 2016 — AtriCure Inc. announced U.S.
microtubules, heartbeat mechanics, Perelman School of Medicine study

Microtubules in a cardiomyocyte at rest (top) and when compressed. Image courtesy of the lab of Ben Prosser, Ph.D., Perelman School of Medicine, University of Pennsylvania

News | EP Lab| April 29, 2016
Using new high-resolution microscopy, researchers have found that molecular struts called microtubules (MT) interact...
Boston Scientific, FDA, ImageReady MR-Conditional Pacing System
Technology | EP Lab| April 28, 2016
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for a suite of products deemed safe for...
breast cancer, herceptin chemotherapy drug, heart damage, monitoring, Journal of Clinical Oncology study
News | Cardiac Diagnostics| April 28, 2016
April 28, 2016 — Breast cancer patients undergoing treatment with trastuzumab-containing regimens should be monitored
Feature | Business| April 28, 2016 | Dave Fornell
 
coronary CT angiography, CCTA, SCOT-HEART trial substudy, SCCT
News | Computed Tomography (CT)| April 26, 2016
The results of a secondary analysis of the SCOT-HEART trial show that coronary computed tomography angiography (CCTA)...
sleep patterns, metabolic syndrome, risk factors, ACC study
News | Cardiac Diagnostics| April 26, 2016
Taking long naps or being excessively tired during the day is associated with a higher risk for developing metabolic...
Auris Surgical Robotics, acquisition, Hansen Medical
News | Robotic Systems| April 26, 2016
Auris Surgical Robotics Inc. and Hansen Medical Inc. announced that they have signed a definitive merger agreement...
Overlay Init